MODULE
2012-2013 Psychiatric Pharmacy Review Course - ACPE Credit Only
The Psychiatric Pharmacy Review Course (Review Course) is an excellent course of study and resource for those seeking a review of psychopharmacology and current standards of care.
The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The 2012-2013 APNA Endorsed Psychiatric Pharmacotherapy Review Course is a knowledge-based course and will provide up to 20 contact hours (2.0 CEUs) of continuing education credit.Genoa Neuropsychiatric Pharmacy Learning Module: Substance Abuse
At the end of this program, the participant should be able to:
-
Identify signs and symptoms of acute intoxication, acute withdrawal, and chronic dependency associated with the use of the following drugs of abuse:
- Alcohol
- Opiates (pain medications, heroin)
- Nicotine
- Cocaine
- Stimulants (Methamphetamines)
- Inhalants
- Marijuana
- Describe the pharmacologic properties and pharmacokinetic parameters for drug therapies used in the treatment of substance use disorders.
- Select appropriate pharmacotherapy (agent, dose, duration of therapy) for substance use disorders based on current practice guidelines.
- Develop a monitoring plan that includes assessment of efficacy, and evaluation for adverse effects, drug interactions, and toxicity given a patient undergoing treatment for a substance use disorder,
- Compose a management strategy given a specific drug-related problem in a patient with a substance use disorder.
- Develop a plan to provide appropriate patient education for substance use disorders
Genoa Neuropsychiatric Pharmacy Learning Module: Sleep Disorders
At the end of this program, the participant should be able to:
- Outline a comprehensive clinical assessment of patient sleep complaints.
- Design an individualized treatment plan for patients of different ages and psychiatric diagnoses with sleep complaints.
- Assess an individual’s clinical presentation and the appropriateness of drug therapy to treat periodic limb movements during sleep (PLMS), restless legs syndrome, obstructive sleep apnea, or narcolepsy.
- Given an individual patient’s type of insomnia, justify the decision to prescribe one hypnotic over another for the management of chronic insomnia.
- Given an individual patient’s sleep disorder diagnoses and drug therapy regimen, judge the safety of that regimen after screening for drug interactions, appropriate dose and timing of medication administration, and duration of treatment.
- Identify the use of accurate information and optimal language for counseling a patient on the safe and effective use of hypnotic medication to manage sleep complaints.
Genoa Neuropsychiatric Pharmacy Learning Module: Schizophrenia
At the end of this program, the participant should be able to:
- Evaluate within a case example whether the patient meets DSM-IV-TR criteria for schizophrenia, schizoaffective disorder, schizophreniform, brief reactive psychosis, or substance-induced psychotic disorder.
- Analyze the appropriateness and results of commonly used rating scales for the evaluation and management of schizophrenia.
- Differentiate among all antipsychotics with regards to efficacy, adverse reactions, dosing, and monitoring.
- Design a monitoring plan for patients on antipsychotic medications for movement disorders using appropriate rating scales.
- Compare and contrast the various treatment guidelines for the management of schizophrenia.
- Assess the use of antipsychotics in special populations (e.g., treatment refractory, pregnancy/lactation).
- Solve drug therapy problems in patients with schizophrenia and/or movement disorders through the provision of appropriate patient education.